ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Consumer Non-Durables

Rohto Pharmaceutical Co., Ltd.

Business Summary

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2021 JPYUSD
Revenue181,053M1,707.12M
Gross Profit104,917M989.24M
Operating income21,867M206.18M
Income before tax23,006M216.92M
Net income16,743M157.86M
EBITDA28,615M269.80M
Diluted EPS146.351.38
Dividends Per Share280.26
Total Assets225,790M2,043.34M
Total liabilities69,176M626.02M
Total equity155,908M1,410.93M
Operating cash flow20,008M188.65M
Currency in JPYCurrency in USD

Historical Data

 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 154,599M 171,795M 183,672M 188,375M 181,053M
Gross Profit 90,012M 99,771M 108,322M 112,697M 104,917M
Operating income 15,452M 18,755M 20,551M 22,882M 21,867M
Income before tax 14,752M 16,820M 16,300M 21,730M 23,006M
Net income 10,011M 9,289M 9,800M 15,409M 16,743M
EBITDA 21,375M 24,669M 26,955M 29,819M 28,615M
Diluted EPS 87.57 81.19 85.65 134.71 146.35
Dividends Per Share 21 22 25 26 28
Total Assets 181,543M 198,166M 200,953M 215,301M 225,790M
Total liabilities 63,145M 69,723M 68,762M 75,266M 69,176M
Total equity 118,002M 127,685M 131,272M 139,283M 155,908M
Operating cash flow 13,428M 19,154M 21,745M 19,040M 20,008M
 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 1,427.67M 1,550.04M 1,656.27M 1,732.56M 1,707.12M
Gross Profit 831.23M 900.19M 976.80M 1,036.52M 989.24M
Operating income 142.69M 169.21M 185.32M 210.45M 206.18M
Income before tax 136.22M 151.76M 146.98M 199.86M 216.92M
Net income 92.44M 83.81M 88.37M 141.72M 157.86M
EBITDA 197.39M 222.57M 243.06M 274.25M 269.80M
Diluted EPS 0.80 0.73 0.77 1.23 1.38
Dividends Per Share 0.19 0.19 0.22 0.23 0.26
Total Assets 1,629.21M 1,863.33M 1,815.53M 1,994.35M 2,043.34M
Total liabilities 566.67M 655.59M 621.24M 697.19M 626.02M
Total equity 1,058.97M 1,200.61M 1,185.99M 1,290.19M 1,410.93M
Operating cash flow 124.00M 172.81M 196.08M 175.11M 188.65M

Valuation Measures

Mar 2021
PER20.11
ROA7.59%
ROE11.34%
Operating margin12.07%
Profit margin9.24%

Key executives

  • President & Representative Director: Masashi Sugimoto
  • Manager-Accounting & Finance: Masamitsu Inoue
  • Director & Vice President: Masaya Saito
  • Senior Executive Officer: Yasuhiro Yamada
  • Senior Executive Officer: Masako Chikaraishi

Shareholders

  • MFS International (UK) Ltd. (8.3%)
  • SPARX Asset Management Co., Ltd. (7.0%)
  • Rohto Pharmaceutical Co., Ltd. (3.4%)
  • Mitsubishi UFJ Financial Group, Inc. (3.2%)
  • Nomura Asset Management Co., Ltd. (2.6%)
  • YAMADA KIYOKO (2.5%)
  • YAMADA FAMILY /ROHTO PHARMACEUTICAL/ (2.3%)
  • Yamada Kosan KK /Hyogo/ (2.1%)
  • The Vanguard Group, Inc. (1.9%)
  • Nippon Life Insurance Co. (1.7%)

Contact Details

  • Website:http://www.rohto.co.jp
  • Address: 1-8-1 Tatsumi-nishi, Ikuno-Ku, Osaka, 544-8666, Japan
  • Phone: +81.6.6758.1231

Related Companies

  • Interstem Co., Ltd.
  • Ophthalmos SA
  • A.J. North (Pty) Ltd.
  • Mayado Pharmaceutical Co., Ltd.
  • Episteme Trading (Shanghai) Co. Ltd.
  • Mentholatum (Asia Pacific) Ltd.
  • Mentholatum (China) Pharmaceuticals Co. Ltd.
  • Rohto Asia Herb (Thailand) Co. Ltd.
  • Mentholatum de Mexico SA de CV
  • Mentholatum Taiwan Ltd.
  • Mentholatum Australasia Pty Ltd.
  • Rohto-Mentholatum (Bangladesh) Ltd.
  • Rohto-Mentholatum (Malaysia) Sdn. Bhd.
  • Rohto-Mentholatum Thailand Ltd.
  • Rohto Pharma (India) Pvt Ltd.
  • Tianjin Rohto Herbal Medicine Co., Ltd.
  • Rohto Pharmaceutical Employee Incentive Plan
  • Hokushinfoods Co., Ltd.
  • Nitten Pharmaceutical Co., Ltd.
  • Rohto Pharmaceutical Employee Stock Ownership Plan
  • Rohto-Mentholatum (Vietnam) Co., Ltd.
  • Medi Care Systems Co. Ltd.
  • Megro Chemical Industry Co. Ltd.
  • Mentholatum Co. Ltd.
  • Qualitech Pharma Co., Ltd.
  • Agera Laboratories, Inc.
  • Mentholatum Co., Inc.
  • MG Pharma

Competitors

  • Do Day Dream Public Co. Ltd.
Last Updated on 16 Jun, 2021

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more